The Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia - A Prospective Open-Label Multicenter Study
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2015
At a glance
- Drugs Amisulpride (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms ESCAPE
- Sponsors Sanofi
- 28 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2013 Planned End Date changed from 1 Jan 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 25 Feb 2013 New trial record